 trial antimycobacterial therapy Crohn disease Clofazimine versus placebo order effect clofazimine powerful antimycobacterial antiinflammatory agent patients active Crohn disease corticosteroids clofazimine mg daily steroids placebo total patients disease remission clofazimine placebo NS fall disease activity score Patients months clofazimine placebo remission study clofazimine placebo NS Side effects minor skin rash increased pigmentation Clofazimine solitary antimycobacterial agent ineffective remission Crohn disease role disease maintenance combination chemotherapy